Effects of a Massive Open Online Course on osteoarthritis knowledge and pain self-efficacy in people with hip and/or knee osteoarthritis: protocol for the MOOC-OA randomised controlled trial.
E-learning
Knowledge
Osteoarthritis
Patient education
RCT
Self-efficacy
Trial
Journal
BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565
Informations de publication
Date de publication:
15 May 2023
15 May 2023
Historique:
received:
21
04
2023
accepted:
26
04
2023
medline:
17
5
2023
pubmed:
16
5
2023
entrez:
15
5
2023
Statut:
epublish
Résumé
Osteoarthritis (OA) is a prevalent, chronic joint condition that commonly affects the knee and hip causing pain, impaired function, and reduced quality of life. As there is no cure, the main goal of treatment is to alleviate symptoms via ongoing self-management predominantly consisting of exercise and weight loss (if indicated). However, many people with OA do not feel adequately informed about their condition and management options to self-manage effectively. Patient education is recommended by all OA Clinical Practice Guidelines to support appropriate self-management, but little is known about the optimal delivery method and content. Massive Open Online Courses (MOOCs) are free, interactive, e-learning courses. They have been used to deliver patient education in other chronic health conditions but have not been used in OA. A two-arm parallel-design, assessor- and participant-blinded superiority randomised controlled trial. People with persistent knee/hip pain consistent with a clinical diagnosis of knee/hip OA (n = 120) are being recruited from the Australia-wide community. Participants are randomly allocated into one of two groups i) electronic information pamphlet (control group) or ii) MOOC (experimental group). Those allocated to the control group receive access to an electronic pamphlet about OA and its recommended management, currently available from a reputable consumer organisation. Those allocated to the MOOC receive access to a 4-week 4-module interactive consumer-facing e-Learning course about OA and its recommended management. Course design was informed by behaviour theory and learning science, and consumer preferences. The two primary outcomes are OA knowledge and pain self-efficacy with a primary endpoint of 5 weeks and a secondary endpoint of 13 weeks. Secondary outcomes include measures of fear of movement, exercise self-efficacy, illness perceptions, OA management and health professional care seeking intentions, physical activity levels, and actual use of physical activity/exercise and weight loss, pain medication, and health professional care seeking to manage joint symptoms. Clinical outcomes and process measures are also collected. Findings will determine whether a comprehensive consumer-facing MOOC improves OA knowledge and confidence to self-manage joint pain compared to a currently available electronic OA information pamphlet. Prospectively registered (Australian New Zealand Clinical Trials Registry ID: ACTRN12622001490763).
Sections du résumé
BACKGROUND
BACKGROUND
Osteoarthritis (OA) is a prevalent, chronic joint condition that commonly affects the knee and hip causing pain, impaired function, and reduced quality of life. As there is no cure, the main goal of treatment is to alleviate symptoms via ongoing self-management predominantly consisting of exercise and weight loss (if indicated). However, many people with OA do not feel adequately informed about their condition and management options to self-manage effectively. Patient education is recommended by all OA Clinical Practice Guidelines to support appropriate self-management, but little is known about the optimal delivery method and content. Massive Open Online Courses (MOOCs) are free, interactive, e-learning courses. They have been used to deliver patient education in other chronic health conditions but have not been used in OA.
METHODS
METHODS
A two-arm parallel-design, assessor- and participant-blinded superiority randomised controlled trial. People with persistent knee/hip pain consistent with a clinical diagnosis of knee/hip OA (n = 120) are being recruited from the Australia-wide community. Participants are randomly allocated into one of two groups i) electronic information pamphlet (control group) or ii) MOOC (experimental group). Those allocated to the control group receive access to an electronic pamphlet about OA and its recommended management, currently available from a reputable consumer organisation. Those allocated to the MOOC receive access to a 4-week 4-module interactive consumer-facing e-Learning course about OA and its recommended management. Course design was informed by behaviour theory and learning science, and consumer preferences. The two primary outcomes are OA knowledge and pain self-efficacy with a primary endpoint of 5 weeks and a secondary endpoint of 13 weeks. Secondary outcomes include measures of fear of movement, exercise self-efficacy, illness perceptions, OA management and health professional care seeking intentions, physical activity levels, and actual use of physical activity/exercise and weight loss, pain medication, and health professional care seeking to manage joint symptoms. Clinical outcomes and process measures are also collected.
DISCUSSION
CONCLUSIONS
Findings will determine whether a comprehensive consumer-facing MOOC improves OA knowledge and confidence to self-manage joint pain compared to a currently available electronic OA information pamphlet.
TRIAL REGISTRATION
BACKGROUND
Prospectively registered (Australian New Zealand Clinical Trials Registry ID: ACTRN12622001490763).
Identifiants
pubmed: 37189094
doi: 10.1186/s12891-023-06467-x
pii: 10.1186/s12891-023-06467-x
pmc: PMC10184332
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
381Informations de copyright
© 2023. The Author(s).
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Acta Orthop. 2020 Feb;91(1):82-87
pubmed: 31635504
N Engl J Med. 2015 Oct 22;373(17):1597-606
pubmed: 26488691
Lancet. 2019 Apr 27;393(10182):1745-1759
pubmed: 31034380
Psychol Rev. 1977 Mar;84(2):191-215
pubmed: 847061
Musculoskeletal Care. 2022 Dec 27;:
pubmed: 36573463
Arthritis Care Res (Hoboken). 2015 May;67(6):809-16
pubmed: 25418120
J Psychosom Res. 2006 Jun;60(6):631-7
pubmed: 16731240
BMC Public Health. 2013 Jul 16;13:658
pubmed: 23855504
Arthritis Rheum. 2003 Apr 15;49(2):156-63
pubmed: 12687505
Br J Sports Med. 2010 Nov;44(14):1029-34
pubmed: 19474003
J Rheumatol. 1988 Dec;15(12):1833-40
pubmed: 3068365
Osteoarthritis Cartilage. 2020 Feb;28(2):154-166
pubmed: 31838047
Arthritis Care Res (Hoboken). 2015 Jul;67(7):913-22
pubmed: 25630944
Nurs Res. 2000 May-Jun;49(3):154-9
pubmed: 10882320
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
J Behav Med. 2016 Dec;39(6):935-946
pubmed: 27515801
Rev Panam Salud Publica. 2015 Dec;38(6):506-14
pubmed: 27440100
Arthritis Rheum. 1989 Jan;32(1):37-44
pubmed: 2912463
Osteoarthritis Cartilage. 2022 Oct;30(10):1398-1410
pubmed: 35750241
Osteoarthr Cartil Open. 2021 Apr 09;3(2):100160
pubmed: 36474995
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
J Orthop Sports Phys Ther. 2022 May;52(5):276-286
pubmed: 34905960